Optimizing the time of day of influenza vaccine administration in adults aged 60-85 years: A randomized controlled trial
Latest Information Update: 16 Aug 2024
At a glance
- Drugs Pneumococcal 23-valent vaccine Walvax Biotechnology (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- Acronyms Chrono-Vax
- 22 Jul 2024 New trial record
- 15 Jul 2024 Status changed from not yet recruiting to recruiting.